Navigation Links
AlphaDetail Revenue Soars 30% in 2010
Date:2/10/2011

SAN MATEO, Calif., Feb. 10, 2011 /PRNewswire/ -- AlphaDetail, a leader in global primary market research for the pharmaceutical and biotech industries, reported a 30% increase in revenue in 2010, exceeding $18.5M in annual revenue for the first time in the company's history.

"Our clients have delivered a loud and clear message that AlphaDetail provides the marketing research solutions that get at the heart of their strategic information needs," says Rishi Varma, CEO and President of AlphaDetail. "Our performance in 2010 makes us one of the fastest growing market research companies in the United States."

The company's record performance included major advances across a broad array of clients and product lines. Major contributors to revenue growth include:

  • Global studies increased 120% with strong growth from Emerging Markets
  • Early stage product profile testing and market modeling increased 114% supported by advances in discrete choice techniques
  • ATU / Tracking solutions increased 44% bolstered by portfolio-wide solutions supported by the AlphaMonitor™ web-based portal
  • KOL mapping increased 17% fueled by key new product enhancements that more closely integrate multiple sources of information into a holistic understanding of influence
  • Revenues from the 5 largest clients grew 48% while the company simultaneously broadened its overall client base.

Rishi Varma continued, "We approach AlphaDetail's 10 year anniversary with strong growth, an expanding portfolio of offerings, a world-class team, and the highest client satisfaction scores in the industry."

About AlphaDetail, Inc.:

At AlphaDetail, we have an unparalleled commitment to our clients. We are a full-service primary market research firm, with a particular emphasis in large and complex quantitative studies for the global healthcare community. AlphaDetail is built on one of the industry's strongest foundations that includes a large team of exceptional analytical specialists, the industry's leading technology platform and a flexible approach to research that helps us to answer our client's most challenging questions.


'/>"/>
SOURCE AlphaDetail, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AlphaDetail, Inc. Enhances Methodology / Advanced Analytics Capabilities
2. AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed
3. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
4. Solos Endoscopy, Inc. Reports $34,291 in Sales Revenue for January 2011
5. Spectros Corporation Sales and Licensing Revenue Up 32% in 2010
6. Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
7. Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
8. Solos Endoscopy, Inc. Reports $90,005 in Sales Revenue for Fourth Quarter 2010
9. Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56
10. Weikang Bio-Technology Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
11. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):